The SAG1 Toxoplasma gondii surface protein is not required for acute ocular toxoplasmosis in mice

Infection and Immunity

Volumn 75, Issue 4, 2007, Pages 2079-2083

  Charles, Elizabeth ^a   Callegan, Michelle C ^a   Blader, Ira J ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE PROTEIN; MEMBRANE PROTEIN; PROTEIN SAG1; UNCLASSIFIED DRUG;

ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; EYE; ILEITIS; INTESTINE INJURY; MOUSE; NONHUMAN; PARASITE; PARASITE DEVELOPMENT; PRIORITY JOURNAL; PROTEIN FUNCTION; RETINA INJURY; TOXOPLASMA GONDII; TOXOPLASMOSIS; WILD TYPE;

ANIMALS; ANTIGENS, PROTOZOAN; DISEASE MODELS, ANIMAL; EYE; GENE DELETION; HISTOCYTOCHEMISTRY; MICE; MICE, INBRED C57BL; MICROSCOPY; PROTOZOAN PROTEINS; RETINA; TOXOPLASMA; TOXOPLASMOSIS, OCULAR; VIRULENCE FACTORS;

EID: 34147181059     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.01685-06     Document Type: Article

References (35)

1. Ajzenberg, D., N. Cogne, L. Paris, M. H. Bessieres, P. Thulliez, D. Filisetti, H. Pelloux, P. Marty, and M. L. Darde. 2002. Genotype of 86 Toxoplasma gondii isolates associated with human congenital toxoplasmosis, and correlation with clinical findings. J. Infect. Dis. 186:684-689.
2. 3H-fucose incorporation in the developing mouse retina. Investig. Ophthalmol. Vis. Sci. 19:457-467.
3. Culbertson, W. W., K. F. Tabbara, and R. O'Connor. 1982. Experimental ocular toxoplasmosis in primates. Arch. Ophthalmol. 100:321-323.
4. Engelbert, M., and M. S. Gilmore. 2005. Fas ligand but not complement is critical for control of experimental Staphylococcus aureus endophthalmitis. Investig. Ophthalmol. Vis. Sci. 46:2479-2486.
5. Eyles, D. E., and N. Coleman. 1956. Relationship of size of inoculum to time to death in mice infected with Toxoplasma gondii. J. Parasitol. 42:272-276.
6. Gazzinelli, R. T., A. Brezin, Q. Li, R. B. Nussenblatt, and C. C. Chan. 1994. Toxoplasma gondii: acquired ocular toxoplasmosis in the murine model, protective role of TNF-alpha and IFN-gamma. Exp. Parasitol. 78:217-229.
7. Gormley, P. D., C. E. Pavesio, P. Luthert, and S. Lightman. 1999. Retinochoroiditis is induced by oral administration of Toxoplasma gondii cysts in the hamster model. Exp. Eye Res. 68:657-661.
8. Grigg, M. E., J. Ganatra, J. C. Boothroyd, and T. P. Margolis. 2001. Unusual abundance of atypical strains associated with human ocular toxoplasmosis. J. Infect. Dis. 184:633-639.
9. Grossniklaus, H. E., C. S. Specht, G. Allaire, and J. A. Leavitt. 1990. Toxoplasma gondii retinochoroiditis and optic neuritis in acquired immune deficiency syndrome. Report of a case. Ophthalmology 97:1342-1346.
10. Holland, G. N. 2003. Ocular toxoplasmosis: a global reassessment. Part I. Epidemiology and course of disease. Am. J. Ophthalmol. 136:973-988.
11. Holland, G. N., G. R. O'Connor, R. Belfort, and J. S. Remington. 1996. Toxoplasmosis, p. 1183-1223. In J. Pepose, G. N. Holland, and K. R. Wilhelmus (ed.), Ocular infection and immunity. Mosby, St. Louis, MO.
12. Holland, G. N., G. R. O'Connor, R. F. Diaz, P. Minasi, and W. M. Wara. 1988. Ocular toxoplasmosis in immunosuppressed nonhuman primates. Investig. Ophthalmol. Vis. Sci. 29:835-842.
13. Hu, M. S., J. D. Schwartzman, A. C. Lepage, I. A. Khan, and L. H. Kasper. 1999. Experimental ocular toxoplasmosis induced in naive and preinfected mice by intracameral inoculation. Ocul. Immunol. Inflamm. 7:17-26.
14. Hu, M. S., J. D. Schwartzman, G. R. Yeaman, J. Collins, R. Seguin, I. A. Khan, and L. H. Kasper. 1999. Fas-FasL interaction involved in pathogenesis of ocular toxoplasmosis in mice. Infect. Immun. 67:928-935.
15. Lekutis, C., D. J. Ferguson, M. E. Grigg, M. Camps, and J. C. Boothroyd. 2001. Surface antigens of Toxoplasma gondii: variations on a theme. Int. J. Parasitol. 31:1285-1292.
16. Lin, M.-H., T.-C. Chen, T.-T. Kuo, C.-C. Tseng, and C.-P. Tseng. 2000. Real-time PCR for quantitative detection of Toxoplasma gondii. J. Clin. Microbiol. 38:4121-4125.
17. Lu, F., S. Huang, M. S. Hu, and L. H. Kasper. 2005. Experimental ocular toxoplasmosis in genetically susceptible and resistant mice. Infect. Immun. 73:5160-5165.
18. Luft, B. J., and J. S. Remington. 1992. Toxoplasmic encephalitis in AIDS. Clin. Infect. Dis. 15:211-222.
19. Lyons, R. E., J. P. Anthony, D. J. Ferguson, N. Byrne, J. Alexander, F. Roberts, and C. W. Roberts. 2001. Immunological studies of chronic ocular toxoplasmosis: up-regulation of major histocompatibility complex class I and transforming growth factor beta and a protective role for interleukin-6. Infect. Immun. 69:2589-2595.
20. Mali, R. S., M. Cheng, and S. K. Chintala. 2005. Intravitreous injection of a membrane depolarization agent causes retinal degeneration via matrix metalloproteinase-9. Investig. Ophthalmol. Vis. Sci. 46:2125-2132.
21. Mineo, J. R., I. A. Khan, and L. H. Kasper. 1994. Toxoplasma gondii: a monoclonal antibody that inhibits intracellular replication. Exp. Parasitol. 79:351-361.
22. Mineo, J. R., R. McLeod, D. Mack, J. Smith, I. A. Khan, K. H. Ely, and L. H. Kasper. 1993. Antibodies to Toxoplasma gondii major surface protein (SAG-1, P30) inhibit infection of host cells and are produced in murine intestine after peroral infection. J. Immunol. 150:3951-3964.
23. Mordue, D. G., F. Monroy, M. La Regina, C. A. Dinarello, and L. D. Sibley. 2001. Acute toxoplasmosis leads to lethal overproduction of Th1 cytokines. J. Immunol. 167:4574-4584.
24. Norose, K., F. Aosai, A. Mizota, S. Yamamoto, H. S. Mun, and A. Yano. 2005. Deterioration of visual function as examined by electroretinograms in Toxoplasma gondii-infected IFN-γ-knockout mice. Investig. Ophthalmol. Vis. Sci. 46:317-321.
25. Norose, K., H. S. Mun, F. Aosai, M. Chen, L. X. Piao, M. Kobayashi, Y. Iwakura, and A. Yano. 2003. IFN-gamma-regulated Toxoplasma gondii distribution and load in the murine eye. Investig. Ophthalmol. Vis. Sci. 44:4375-4381.
26. Nozik, R. A., and G. R. O'Connor. 1968. Experimental toxoplasmic retinochoroiditis. Arch. Ophthalmol. 79:485-489.
27. Pavesio, C. E., M. L. Chiappino, P. Gormley, P. Y. Setzer, and B. A. Nichols. 1995. Acquired retinochoroiditis in hamsters inoculated with ME 49 strain Toxoplasma. Investig. Ophthalmol. Vis. Sci. 36:2166-2175.
28. Rachinel, N., D. Buzoni-Gatel, C. Dutta, F. J. Mennechet, S. Luangsay, L. A. Minns, M. E. Grigg, S. Tomavo, J. C. Boothroyd, and L. H. Kasper. 2004. The induction of acute ileitis by a single microbial antigen of Toxoplasma gondii. J. Immunol. 173:2725-2735.
29. Ramadan, R. T., R. Ramirez, B. D. Novosad, and M. C. Callegan. 2006. Acute inflammation and loss of retinal architecture and function during experimental Bacillus endophthalmitis. Curr. Eye Res. 31:955-965.
30. Riemslag, F. C., C. J. Brinkman, H. F. Verduyn Lunel, H. Spekreijse, and A. Kijlstra. 1992. Analysis of the electroretinogram in toxoplasma retinochorioiditis. Doc. Ophthalmol. 82:57-63.
31. Roberts, F., and R. McLeod. 1999. Pathogenesis of toxoplasmic retinochoroiditis. Parasitol. Today 15:51-57.
32. Roberts, F., C. W. Roberts, D. J. Ferguson, and R. McLeod. 2000. Inhibition of nitric oxide production exacerbates chronic ocular toxoplasmosis. Parasite. Immunol. 22:1-5.
33. Rosenbaum, J. T., P. Kievit, Y. B. Han, J. M. Park, and S. R. Planck. 1998. Interleukin-6 does not mediate endotoxin-induced uveitis in mice: studies in gene deletion animals. Investig. Ophthalmol. Vis. Sci. 39:64-69.
34. Tedesco, R. C., R. L. Smith, S. Corte-Real, and K. S. Calabrese. 2005. Ocular toxoplasmosis in mice: comparison of two routes of infection. Parasitology 131:303-307.
35. Weiss, L. M., and K. Kim. 2000. The development and biology of bradyzoites of Toxoplasma gondii. Front. Biosci. 5:D391-D405.